These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7822107)

  • 1. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
    Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
    Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations.
    Segawa M; Ohno Y; Doi M; Ishida T; Iwashita T
    Int J Pept Protein Res; 1995 Jul; 46(1):37-46. PubMed ID: 7558595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation of deltorphin-II in membrane environment studied by two-dimensional NMR spectroscopy and molecular dynamics calculations.
    Ohno Y; Segawa M; Ohishi H; Doi M; Kitamura K; Ishida T; Inoue M; Iwashita T
    Eur J Biochem; 1993 Feb; 212(1):185-91. PubMed ID: 8383038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New features of the delta opioid receptor: conformational properties of deltorphin I analogues.
    Balboni G; Marastoni M; Picone D; Salvadori S; Tancredi T; Temussi PA; Tomatis R
    Biochem Biophys Res Commun; 1990 Jun; 169(2):617-22. PubMed ID: 2162669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation-activity relationships of cyclo-constrained micro/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin.
    Rodziewicz-Motowidło S; Czaplewski C; Luczak S; Ciarkowski J
    J Pept Sci; 2008 Aug; 14(8):898-902. PubMed ID: 18338322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S; Sagan S; Delfour A; Nicolas P
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
    Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
    Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folded conformations of the delta-selective opioid dermenkephalin with head-to-tail interactions. A simulated annealing study through NMR restraints.
    Naim M; Nicolas P; Baron D
    Int J Pept Protein Res; 1996 May; 47(5):353-60. PubMed ID: 8791158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the conformational meaning of "delta-address" in the dermenkephalin sequence.
    Nikiforovich GV; Hruby VJ
    Biochem Biophys Res Commun; 1990 Dec; 173(2):521-7. PubMed ID: 1979733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational properties of deltorphin: new features of the delta-opioid receptor.
    Temussi PA; Picone D; Tancredi T; Tomatis R; Salvadori S; Marastoni M; Balboni G
    FEBS Lett; 1989 Apr; 247(2):283-8. PubMed ID: 2541018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity of new mu and delta opioid peptides.
    Capasso A
    Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution conformations of deltorphin-I obtained from combined use of quantitative 2D-NMR and energy calculations: a comparison with dermenkephalin.
    Naim M; Nicolas P; Benajiba A; Baron D
    J Pept Res; 1998 Dec; 52(6):443-56. PubMed ID: 9924989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide.
    Duchesne D; Naim M; Nicolas P; Baron D
    Biochem Biophys Res Commun; 1993 Sep; 195(2):630-6. PubMed ID: 8373402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
    Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
    Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
    Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH
    Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mu-selective heptapeptide opioid dermorphin has two conformations around Phe3 psi with no head-to-tail interaction. A quantitative 2-D NMR and molecular modeling analysis.
    Riand J; Nicolas P; Baron D
    J Biomol Struct Dyn; 2002 Dec; 20(3):359-73. PubMed ID: 12437374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid in DMSO solution, by 1H NMR spectroscopy and molecular modeling calculation.
    In Y; Minoura K; Ohishi H; Minakata H; Kamigauchi M; Sugiura M; Ishida T
    J Pept Res; 2001 Nov; 58(5):399-412. PubMed ID: 11892849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational restriction of Tyr and Phe side chains in opioid peptides: information about preferred and bioactive side-chain topology.
    Tourwé D; Verschueren K; Frycia A; Davis P; Porreca F; Hruby VJ; Toth G; Jaspers H; Verheyden P; Van Binst G
    Biopolymers; 1996 Jan; 38(1):1-12. PubMed ID: 8679939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pKa and volume of residue one influence delta/mu opioid binding: QSAR analysis of tyrosine replacement in a nonselective deltorphin analogue.
    Heyl DL; Schullery SE; Renganathan K; Jayamaha MN; Rodgers DW; Traynor JR
    Bioorg Med Chem; 2003 Aug; 11(17):3761-8. PubMed ID: 12901921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.